We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Freeslate Integrates the DropSense96TM for Biologics Quantification on its Biologics Formulation System

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Freeslate Integrates the DropSense96TM for Biologics Quantification on its Biologics Formulation System"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Freeslate, Inc., and Trinean, NV., have announced the integration of the DropSense96TM with the CM3 product line for biotherapeutics formulation and optimization.

Based on the CM3 automation platform, the Freeslate Biologics Formulation System offers high throughput formulation, stressing, and analysis. Integration of the DropSense96TM provides CM3 users the ability to quickly determine protein concentration without dilution steps. This increases system accuracy and results in faster workflows.

“The full automation of the DropSense96TM with Freeslate’s Biologics Formulation System allows users to dramatically increase the throughput of their analysis. The ability to prepare, stress, and analyze all in one workflow means greater efficiency and enhanced decision making for our users,” add Philippe Stas, CEO of Trinean. “Working together with the Freeslate teams to optimize the workflows has been very rewarding.”

“With a number of seamless integrations of the DropSense96TM with our platform, we have selected the instrument as our preferred option for quantification of biologics,” said John S. Senaldi, President and CEO of Freeslate. “Its unique design combining speed, minimal sample usage, and an unmet measurement range allows for fast, yet robust quantification of protein samples thereby significantly shortening the screening process in biotherapeutic drug development.”

The Trinean DropSense96TM UV/VIS droplet reader is designed for high throughput analysis of biological samples. Its unique microfluidic 96-well format allows for quantification of samples as small as 2 microliter in a fully automated workflow. The Trinean software toolbox is available for detailed sample QC, workflow integration, and compliance in regulatory environments.

Freeslate’s Lab Execution and Analysis (LEA) software seamlessly manages the entire experimental process from design and execution to data analysis and report sharing. It allows users to design complex experiments quickly using its logical, recipe-oriented approach, and experimental conditions can be linked to analytical data for easy viewing and reporting. Using LEA, third party equipment such as the DropSense96TM plate reader, is fully integrated with Freeslate robotic components and sample data is directly linked to the processing steps and analytical results.

Other standard integrations available with the Biologics Formulation System include fully automated third party instruments such as dynamic light scatter reader, centrifuge, plate sealer, and shaking incubator and off-deck, semi-automated analytical instruments including UPLC, HPLC, cIEF,and cSDS.